Safety of intravenous thrombolysis for patients taking a non-vitamin K antagonist
oral anticoagulant (NOAC) is not established. Herein, a patient with remote intracerebral
hemorrhage (ICH) after thrombolytic therapy under NOAC treatment, is reported. The
patient also presented re-bleeding after early resumption of NOAC treatment.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Guidelines for the Appropriate Treatment with Intravenous rt-PA (alteplase).second ed. Oct 2012 (http://www.jsts.gr.jp/img/rt-PA02.pdf)
- Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.Circulation. 2015; 132: 1261-1269
- Safety of intravenous thrombolysis among stroke patients taking new oral anticoagulants-case series and systematic review of reported cases.J. Stroke Cerebrovasc. Dis. 2015; 24: 2685-2693
- Remote or extraischemic intracerebral hemorrhage–an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.Stroke. 2014; 45: 1657-1663
- Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.Eur. Neurol. 2011; 66: 37-41
- Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study.Stroke. 2015; 46: 2175-2182
- Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation.J. Neurol. Sci. 2013; 331: 90-93
- New appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration.Stroke. 2013; 44: 2776-2781
- Hemorrhagic transformation of cerebral infarction–possible mechanisms.Thromb. Haemost. 1999; 82: 92-94
Article info
Publication history
Published online: May 21, 2016
Accepted:
May 20,
2016
Received in revised form:
May 13,
2016
Received:
March 31,
2016
Identification
Copyright
© 2016 Elsevier B.V. All rights reserved.